Patient Home Monitoring Highlights Record Quarter, Updated M&A Pipeline, and Improved Cross Selling on Q2 FY 2014 Earnings Call

Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on
rolling-up annuity-based healthcare service companies in the U.S. and Canada,
provided highlights of its financial results for the second quarter of fiscal
year 2014 on an earnings call on Wednesday, May 21, 2014 at 4pm EST. 


To listen to the full earnings call please go to the link provided:
http://cc.readytalk.com/play?id=2q15fh  


Participants from PHM were Michael Dalsin (Chairman and CEO), Roger Greene
(Executive Director), and Andrew Folmer (President and CFO). 


About PHM

PHM is an acquisition-oriented, fast-growing and profitable company servicing
patients with heart disease and other chronic health conditions. PHM is focused
on acquiring companies in a highly fragmented and developing market of small
privately-held companies servicing chronically ill patients with multiple
disease states caused mainly by age and obesity. Because of the new and highly
fragmented nature of the market, PHM is actively identifying and evaluating
profitable, annuity-based companies to acquire at favorable prices for their
patient databases and technical expertise. PHM's post-acquisition organic growth
strategy is to increase annual revenue per patient by offering multiple services
to the same patient, consolidating the patient's services and making life easier
for the patient. The expected result is growing EPS with each acquisition and
growing revenue and profits from the cross selling efforts.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.  


Forward-Looking Statements

Information in this news release that is not current or historical factual
information may constitute forward-looking information within the meaning of
securities laws. Implicit in this information, particularly in respect of the
future outlook of PHM and anticipated events or results, are assumptions based
on beliefs of PHM's senior management as well as information currently available
to it. While these assumptions were considered reasonable by PHM at the time of
preparation, they may prove to be incorrect. Readers are cautioned that actual
results are subject to a number of risks and uncertainties, including the
availability of funds and resources to pursue operations, decline of
reimbursement rates, dependence on few payors, possible new drug discoveries, a
novel business model, dependence on key suppliers, granting of permits and
licenses in a highly regulated business, competition, difficulty integrating
newly acquired businesses, low profit market segments as well as general
economic, market and business conditions, and could differ materially from what
is currently expected. This press release refers non-GAAP and non-IFRS financial
measures that do not have standardized meaning prescribed by GAAP or IFRS. PHM's
presentation of these financial measures may not be comparable to similarly
titled measures used by other companies. These financial measures are intended
to provide additional information to investors concerning PHM's performance. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Patient Home Monitoring Corp.
Michael Dalsin
Chairman
[phone]
www.phmhometesting.com